+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Activation of Toll-like receptor 5 on breast cancer cells by flagellin suppresses cell proliferation and tumor growth



Activation of Toll-like receptor 5 on breast cancer cells by flagellin suppresses cell proliferation and tumor growth



Cancer Research 71(7): 2466-2475



Increasing evidence showed that Toll-like receptors (TLR), key receptors in innate immunity, play a role in cancer progression and development but activation of different TLRs might exhibit the exact opposite outcome, antitumor or protumor effects. TLR function has been extensively studied in innate immune cells, so we investigated the role of TLR signaling in breast cancer epithelial cells. We found that TLR5 was highly expressed in breast carcinomas and that TLR5 signaling pathway is overly responsive in breast cancer cells. Interestingly, flagellin/TLR5 signaling in breast cancer cells inhibits cell proliferation and an anchorage-independent growth, a hallmark of tumorigenic transformation. In addition, the secretion of soluble factors induced by flagellin contributed to the growth-inhibitory activity in an autocrine fashion. The inhibitory activity was further confirmed in mouse xenografts of human breast cancer cells. These findings indicate that TLR5 activation by flagellin mediates innate immune response to elicit potent antitumor activity in breast cancer cells themselves, which may serve as a novel therapeutic target for human breast cancer therapy.

(PDF emailed within 0-6 h: $19.90)

Accession: 051342620

Download citation: RISBibTeXText

PMID: 21427357

DOI: 10.1158/0008-5472.CAN-10-1993


Related references

Flagellin promotes the proliferation of gastric cancer cells via the Toll-like receptor 5. International Journal of Molecular Medicine 28(1): 115-119, 2011

Cystatin C deficiency suppresses tumor growth in a breast cancer model through decreased proliferation of tumor cells. Oncotarget 8(43): 73793-73809, 2017

Downregulation of Bmi1 in breast cancer stem cells suppresses tumor growth and proliferation. Oncotarget 8(24): 38731-38742, 2017

Inhibition of FOXM1 transcription factor suppresses cell proliferation and tumor growth of breast cancer. Cancer Gene Therapy 20(2): 117-124, 2013

Knockdown of Rab7a suppresses the proliferation, migration and xenograft tumor growth of breast cancer cells. Bioscience Reports: -, 2018

Targeting of GIT1 by miR-149* in breast cancer suppresses cell proliferation and metastasis in vitro and tumor growth in vivo. Oncotargets and Therapy 10: 5873-5882, 2017

Sunitinib significantly suppresses the proliferation, migration, apoptosis resistance, tumor angiogenesis and growth of triple-negative breast cancers but increases breast cancer stem cells. Vascular Cell 6: 12-12, 2014

shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments. Zhonghua Yi Xue Za Zhi 87(21): 1506-1509, 2007

AIM2 suppresses human breast cancer cell proliferation in vitro and mammary tumor growth in a mouse model. Molecular Cancer Therapeutics 5(1): 1-7, 2006

Antisense to type I insulin-like growth factor receptor suppresses tumor growth of human breast cancer cells. Proceedings of the American Association for Cancer Research Annual Meeting 38(0): 315, 1997

MicroRNA‑320a suppresses tumor cell growth and invasion of human breast cancer by targeting insulin‑like growth factor 1 receptor. Oncology Reports: -, 2018

GD₃ synthase expression enhances proliferation and tumor growth of MDA-MB-231 breast cancer cells through c-Met activation. Molecular Cancer Research 8(11): 1526-1535, 2011

Knockdown of asparagine synthetase (ASNS) suppresses cell proliferation and inhibits tumor growth in gastric cancer cells. Scandinavian Journal of Gastroenterology 51(10): 1220-1226, 2016

Down-regulation of c9orf86 in human breast cancer cells inhibits cell proliferation, invasion and tumor growth and correlates with survival of breast cancer patients. Plos One 8(8): E71764-E71764, 2014

γ-Irradiated cancer cells promote tumor growth by activation of Toll-like receptor 1-mediated inducible nitric oxide synthase in macrophages. Journal of Leukocyte Biology 97(4): 711-721, 2015